Carl-Johan Spak
Director/Board Member at FOLLICUM AB (PUBL)
Network origin in Carl-Johan Spak first degree
Entity | Entity type | Industry | |
---|---|---|---|
Holding Company | Biotechnology | 34 | |
Public Company | Pharmaceuticals: Major | 16 | |
Karolinska Institutet
14
| College/University | Other Consumer Services | 14 |
KAHR Medical Ltd.
KAHR Medical Ltd. Pharmaceuticals: MajorHealth Technology KAHR Medical Ltd. develops novel fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases. Its drug pipeline is built around the signal converter proteins a unique class of multi-functional therapeutic agents that convert signals sent from one cell to another. The firm?s therapeutic proteins integrate two functional units, enabling each one to elicit multiple cooperative functional endpoints. The company was founded by Mark L. Tykocinski in 2005 and is headquartered in Jerusalem, Israel.
11
| Holding Company | Pharmaceuticals: Major | 11 |
Public Company | Electronic Equipment/Instruments | 11 | |
SymCel AB
SymCel AB Medical SpecialtiesHealth Technology SymCel AB develops and markets analytical instrumentations for cell biological research and development. Its products include calScreener, calPlate System, and calView date collection and analysis software. The company was founded by Dan Rolf Stefan Hallen and Bertil Ingemar Wadso in 2004 and is headquartered in Spanga, Sweden.
10
| Holding Company | Medical Specialties | 10 |
Subsidiary | Pharmaceuticals: Major | 10 | |
10
| Public Company | Biotechnology | 10 |
Atrogi AB
Atrogi AB BiotechnologyHealth Technology Atrogi AB is a company that engages in research and development, and develops and sells products related to type 2 diabetes. The company is based in Solna, Sweden. Atrogi was founded in 2013 by Andreas Bhagwani and Tore Bengtsson. Alexandra Ekman Ryding has been the CEO of the Swedish company since 2018.
10
| Holding Company | Biotechnology | 10 |
EpiEndo Pharmaceuticals ehf
EpiEndo Pharmaceuticals ehf BiotechnologyHealth Technology EpiEndo Pharmaceuticals ehf is a clinical-stage biopharmaceutical company based in Reykjavik, Iceland. The Icelander company focuses on enhancing epithelial barrier integrity to treat inflammatory disorders, with a primary focus on chronic respiratory diseases. The company recently appointed Dr. Kate Hanrott as Director of Clinical Operations and Sciences, bringing extensive experience to the role. EpiEndo Pharmaceuticals will be attending the Bio International Convention in June 2023. EpiEndo Pharmaceuticals was founded in 2014 by Fridrik Gardarsson, and Maria Bech has been the CEO of the company since 2021.
10
| Holding Company | Biotechnology | 10 |
Flerie Invest AB
Flerie Invest AB Investment ManagersFinance Flerie Invest AB (Flerie Invest) is a venture capital subsidiary of Flerie Creations Ltd. founded in 2011. The firm is headquartered in Stockholm, Sweden.
7
| Subsidiary | Investment Managers | 7 |
Prokarium Holdings Ltd.
Prokarium Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services Prokarium Holdings Ltd. provides management services. The private company is based in London, UK. The British company was founded in 2014. Kristen Albright has been the CEO of the company since 2018.
5
| Private Company | Miscellaneous Commercial Services | 5 |
Empros Pharma AB
Empros Pharma AB Pharmaceuticals: MajorHealth Technology Empros Pharma AB is a pharmaceutical company based in Sweden that focuses on developing drugs to combat obesity. The CEO is Arvid Söderhäll, and the company is located in Solna, Sweden. The Swedish company has developed a weight-loss combination product containing orlistat and acarbose, which has been tested in a randomized, placebo-controlled trial. Empros Pharma's main drug, EMP16, is designed to delay food digestion and absorption processes in the small intestine using a proprietary advanced drug delivery technology. The company was founded in 2013 by senior researchers and entrepreneurs at Uppsala University, along with external investor Flerie Invest.
4
| Holding Company | Pharmaceuticals: Major | 4 |
Buzzard Pharmaceuticals AB
Buzzard Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Buzzard Pharmaceuticals AB develops oncology drugs. The company is based in Stockholm, Sweden. The Swedish company was founded by Urban Paulsson. The CEO is Maarten de Château.
3
| Holding Company | Pharmaceuticals: Major | 3 |
Provell Pharmaceuticals LLC
Provell Pharmaceuticals LLC Medical DistributorsDistribution Services Provell Pharmaceuticals LLC is a healthcare company, which engages in marketing and distribution of pharmaceutical products. It offers products of Merck KGaA including Euthyrox. The company was founded by Jim Small and Kurt Kalm in 2005 and is headquartered in Honey Brook, PA.
3
| Holding Company | Medical Distributors | 3 |
Recip AB
Recip AB Pharmaceuticals: MajorHealth Technology Part of Viatris, Inc., Recip AB is a private company that manufactures pharmaceutical products. Recip AB is based in Arsta, Sweden. Recip was acquired by Meda AB, part of Viatris, Inc. from August 24, 2016 on December 31, 2007 for $475.65 million.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Prokarium Ltd.
Prokarium Ltd. Miscellaneous Commercial ServicesCommercial Services Prokarium Ltd. operates as a biopharmaceutical company that focuses on developing vaccination solutions based on synthetic biology. Its oral vaccine delivery platform Vaxonella stimulates broad protective immune responses applicable to a wide range of diseases. The company is headquartered in Keele, the United Kingdom.
1
| Holding Company | Miscellaneous Commercial Services | 1 |
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Carl-Johan Spak via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
CONSORT MEDICAL PLC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Helsinn Healthcare SA
Helsinn Healthcare SA Pharmaceuticals: MajorHealth Technology Helsinn Healthcare SA develops and provides licenses for drugs. The firm offers services to oncology, cancer supportive care, pain and inflammation, gastrointestinal fields. The company was founded by Gabriele Braglia in 1976 and is headquartered in Pazzallo, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal Consultant / Advisor | |
Healthinvest Partners AB
Healthinvest Partners AB Investment ManagersFinance Healthinvest Partners AB (Healthinvest) is an alternative investment management firm headquartered in Stockholm, Sweden. The firm was founded by Anders Hallberg and Carl Bennet in 2006. They are owned by Atle Investment Management AB, which is a subsidiary of Bure Equity AB (STO: BURE). Healthinvest manages HealthInvest Alpha Fund – which is an actively managed global healthcare fund with a value-based approach, and HealthInvest Sustainable Healthcare – a global healthcare fund where the investment philosophy is characterized by medical progress and innovation with a strong focus on sustainability. In addition, the firm manages the fund Avanza Healthcare on behalf of Avanza. | Investment Managers | Director/Board Member Director/Board Member | |
KARO PHARMA AB (PUBL) | Pharmaceuticals: Major | Director/Board Member General Counsel Director/Board Member | |
MEDIVIR AB | Pharmaceuticals: Major | Chairman Director/Board Member Chairman Chief Executive Officer Director/Board Member Chief Executive Officer | |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
NEL ASA | Industrial Machinery | Director/Board Member Director/Board Member | |
Chalmers University of Technology | College/University | Director/Board Member Graduate Degree | |
Stockholm School of Economics | College/University | Graduate Degree Graduate Degree Undergraduate Degree Masters Business Admin Masters Business Admin | |
University of Uppsala | College/University | Corporate Officer/Principal Undergraduate Degree Graduate Degree Doctorate Degree Doctorate Degree Doctorate Degree Graduate Degree Graduate Degree Graduate Degree Undergraduate Degree | |
LEO Pharma A/S
LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
University of Stockholm | College/University | Doctorate Degree Graduate Degree Undergraduate Degree Graduate Degree | |
CAMURUS AB | Pharmaceuticals: Major | General Counsel Director/Board Member | |
University of Lund | College/University | Graduate Degree Graduate Degree Corporate Officer/Principal Undergraduate Degree Graduate Degree Doctorate Degree Graduate Degree Graduate Degree | |
Umea Universitet | College/University | Doctorate Degree Corporate Officer/Principal Doctorate Degree | |
Unimedic AB
Unimedic AB Pharmaceuticals: MajorHealth Technology Unimedic AB manufactures and sells pharmaceuticals and chemical engineering products. It offers a wide range of licensed and unlicensed medicines and extemporaneous pharmaceuticals as well as non-prescription heath care products and pharmaceutical aids. The company was founded by Nils Ivrell, Lennart Leyoberg, and Kenth-Olov Norman in 1992 and is headquartered in Matfors, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Royal Swedish Academy of Engineering Sciences
Royal Swedish Academy of Engineering Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Swedish Academy of Engineering Sciences (IVA) is an organization that brings together around 1,300 academy members and 250 companies to bridge the gap between academia, business, and politics. The non-profit company is based in Stockholm, Sweden. The Swedish company's aim is to work towards people's ability to contribute positively to society. The organization runs an internship program called Tekniksprånget, which gives young people in Sweden the opportunity to test the engineering profession through a four-month paid internship. The program has been running since 2012 and aims to inspire more people to choose a higher technical education. The CEO of the company is Björn O. Nilsson. | Miscellaneous Commercial Services | Director/Board Member Chairman Corporate Officer/Principal | |
Recipharm Monts SAS
Recipharm Monts SAS Pharmaceuticals: MajorHealth Technology Part of Recipharm AB, Recipharm Monts SAS is a private company that manufactures sterile injectable anesthetic products. The company is based in Monts, France. Carl Ericson has been the CEO of the French company since 2019. | Pharmaceuticals: Major | Chairman Director/Board Member | |
XENIA VENTURE CAPITAL LTD | Financial Conglomerates | Director/Board Member Director/Board Member | |
HBL - HADASIT BIO-HOLDINGS LTD | Investment Managers | Chief Executive Officer Chairman Director/Board Member | |
SPECTRACURE AB | Electronic Equipment/Instruments | Chairman Chairman | |
Aesica Formulation Development Ltd.
Aesica Formulation Development Ltd. Pharmaceuticals: MajorHealth Technology Aesica Formulation Development Ltd. develops pharmaceutical products. It offers sterile and nutraceutical product development and drug delivery services. The company was founded on December 22, 2005 and is headquartered in Northumberland, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
BIOARCTIC AB | Pharmaceuticals: Major | Chairman Chairman Corporate Officer/Principal | |
Beactica Therapeutics AB
Beactica Therapeutics AB Medical DistributorsDistribution Services Beactica Therapeutics AB operates as a drug discovery company, utilizing its proprietary methodologies to evaluate the interactions of molecules in order to generate novel therapeutics. The firm's services include fragment-based lead generation, kinetic and mechanistic characterization of inhibitors, extended rate analysis, competition analysis, and antibody interaction analysis. The company was founded by Per K?llblad and Ulla Helena Danielson in 2006 and is headquartered in Uppsala, Sweden. | Medical Distributors | Director/Board Member Director/Board Member Director/Board Member | |
Apotek Produktion & Laboratorier AB
Apotek Produktion & Laboratorier AB Pharmaceuticals: MajorHealth Technology Apotek Produktion & Laboratorier AB develops and manufactures pharmaceutical products. Its services include analytical services, clinical trials and contract manufacturing. The company is headquartered in Kungens Kurva, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
EQL PHARMA AB | Pharmaceuticals: Generic | Chairman Director/Board Member | |
SwedenBIO Service AB
SwedenBIO Service AB Miscellaneous Commercial ServicesCommercial Services SwedenBIO Service AB is a non-profit company that develops biotechnology, diagnostics, pharmaceuticals, and medical technology. It also offers counseling, education, opinion formation, and investigations. The company was founded in 2002 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member Director/Board Member | |
Recipharm Ltd.
Recipharm Ltd. Pharmaceuticals: MajorHealth Technology Recipharm Ltd. manufactures pharmaceutical products. It offers branded and generic products. The company was founded on August 10, 2012 and is headquartered in Ashton-under-Lyne, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
OxyPharma AB | Director/Board Member Chairman Chief Executive Officer | ||
SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Aesica Holdco Ltd.
Aesica Holdco Ltd. Pharmaceuticals: MajorHealth Technology Part of Recipharm AB, Aesica Holdco Ltd. operates as a holding British company. The private company is based in Hemel Hempstead, UK. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Cormorant Pharmaceuticals AB
Cormorant Pharmaceuticals AB BiotechnologyHealth Technology Cormorant Pharmaceuticals AB provides biopharmaceutical products.The company was founded by Maarten de Chateau and Urban Paulsson in 2010 and is headquartered in Solna, Sweden. | Biotechnology | Director/Board Member Founder Chief Executive Officer | |
EXEGER Sweden AB
EXEGER Sweden AB Building ProductsProducer Manufacturing EXEGER Sweden AB operates as a screen printing solar cell factory. It also commercializing solar technology. The company was founded by Giovanni Fili in 2009 and is headquartered in Stockholm, Sweden. | Building Products | Director/Board Member Founder | |
Aptahem AB
Aptahem AB Pharmaceuticals: MajorHealth Technology Aptahem AB operates as a biotechnology company. The firm engages in developing drug candidates for the treatment and prevention of disease caused by blockages in blood vessels as the result of blood clots, such as deep vein thrombosis, stroke and heart failure. Its main business model is to clinically develop aptamer-based treatments for life-threatening acute conditions where coagulation and inflammation interact in the disease process. The company was founded byLuiza Jedlina, Bert Junno, Tina Persson and Johan Lindh in 2014 and is headquartered in Malmo, Sweden. | Pharmaceuticals: Major | Chief Operating Officer Chief Operating Officer | |
Sigrid Therapeutics AB
Sigrid Therapeutics AB Medical SpecialtiesHealth Technology Sigrid Therapeutics AB engages in research and development in the area of weight loss and metabolic disorders. It focuses on therapies for prevention and treatment of lifestyle diseases. The company was founded by Sana Alajmovic and Tore Bengtsson in 2014 and is headquartered in Stockholm, Sweden. | Medical Specialties | Director/Board Member Director/Board Member Founder Director/Board Member | |
Sixera Pharma AB
Sixera Pharma AB Pharmaceuticals: GenericHealth Technology Sixera Pharma AB conducts activities within research, development, and commercialization of pharmaceuticals. It develops treatment for Netherton syndrome. The company was founded by Jean Nordstrom on August 21, 2012 and is headquartered in Göteborg, Sweden. | Pharmaceuticals: Generic | Director/Board Member Chief Executive Officer | |
Smartfish AB
Smartfish AB Beverages: Non-AlcoholicConsumer Non-Durables Part of Smartfish AS, Smartfish AB is a Swedish company that focuses on medical nutrition for cancer patients. The private company is based in Solna, Sweden. The company believes that good nutritional status is crucial for successful treatment and optimal outcomes. Smartfish has a slim and flexible organizational structure and aims to grow through strategic relationships with leading R&D, production, and distribution partners. The company's medical nutrition products are used to improve the nutritional status of malnourished or undernourished patients. | Beverages: Non-Alcoholic | Chairman Chief Tech/Sci/R&D Officer | |
Gesynta Pharma AB
Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Gesynta Pharma AB develops and manufactures novel oral treatments for patients with chronic inflammatory conditions. The company was founded by Gunilla Anders Ekström, Charlotte Elisabet Edenius, Urban Paulsson, Ralf Morgenstern, Per-Johan Göte Jakobsson and Patric Stenberg in 2017 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Founder Director/Board Member | |
Nylof Holding AB
Nylof Holding AB Investment Banks/BrokersFinance Nylof Holding AB provides security brokerage services. The private company is based in Stockholm, Sweden. | Investment Banks/Brokers | Director/Board Member Director/Board Member | |
Cinclus Pharma Holding AB
Cinclus Pharma Holding AB BiotechnologyHealth Technology Cinclus Pharma Holding AB is a Swedish pharmaceutical company that focuses on developing clinical stage drug candidates for gastric acid related diseases. The company's drug candidate, linaprazan glurate, takes a new approach to provide improved management of GERD. Gastroesophageal reflux disease, or acid reflux, is a condition in which the content of the stomach regurgitates into the esophagus. The company was founded by pioneers in GERD treatment with extensive experience from Astra and Astra Zeneca. Christer Ahlberg has been the CEO of the company since 2021. | Biotechnology | Director/Board Member Founder | |
Amarna Therapeutics BV
Amarna Therapeutics BV Medical/Nursing ServicesHealth Services Amarna Therapeutics BV operates as a biotechnology company developing SVac viral gene delivery vector platform. The firm has developed a proprietary SuperVero cell line and SVec gene delivery platform for the development of safe and efficient immunotherapies for major indications within the degenerative, inflammatory and autoimmune disease areas. The company was founded by Ben van Leent and Peter de Haan in 2008 and is headquartered in Leiden, the Netherlands. | Medical/Nursing Services | Chairman Director/Board Member Director/Board Member | |
Recipharm Holdings Ltd.
Recipharm Holdings Ltd. MiscellaneousMiscellaneous Recipharm Holdings Ltd. operates from a multipurpose manufacturing facility, The company was founded on August 10, 2012 and is headquartered in Ashton-Under-Lyne, the United Kingdom. | Miscellaneous | Director/Board Member Director/Board Member | |
Cavis Technologies AB | Chairman Director/Board Member | ||
Evident Life Försäkring AB | Chairman Director/Board Member | ||
Cordivest AB | Chairman Chief Executive Officer | ||
NANOLOGICA AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer |
Statistics
International
Sweden | 38 |
United Kingdom | 6 |
Israel | 4 |
Switzerland | 2 |
Norway | 2 |
Sectoral
Health Technology | 27 |
Consumer Services | 7 |
Finance | 5 |
Commercial Services | 4 |
Producer Manufacturing | 3 |
Operational
Director/Board Member | 528 |
Corporate Officer/Principal | 177 |
Chairman | 153 |
Chief Executive Officer | 123 |
Independent Dir/Board Member | 70 |
Most connected contacts
- Stock Market
- Insiders
- Carl-Johan Spak
- Company connections